T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
01. November 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
24. Oktober 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted...
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
23. Oktober 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the...
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
12. Oktober 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
12. Oktober 2023 16:02 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Reverse Stock Split Effective Today
12. Oktober 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Reports Granting of Inducement Award
06. Oktober 2023 16:07 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to...
T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
05. Oktober 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
19. September 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Reports Granting of Inducement Award
15. September 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...